Dr Lu Amy Sun, MD in Brigewater, NJ - Internal Medicine

Dr Lu Amy Sun, MD is a Internal Medicine physician based in Brigewater, New Jersey. Dr Lu Amy Sun is licensed to practice in Pennsylvania (license number 432905) and her current practice location is 55 Corporate Drive, Brigewater, New Jersey. She can be reached at her office (for appointments etc.) via phone at (215) 622-5386.

NPI number for Dr Lu Amy Sun is 1720525827 and her current mailing address is 55 Corporate Drive, Brigewater, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1720525827.

Contact Information

	Dr Lu Amy Sun, MD
	55 Corporate Drive, Brigewater, NJ 08807-2742
	(215) 622-5386
	Not Available

Physician's Profile

Full Name	Dr Lu Amy Sun
Gender	Female
Speciality	Internal Medicine
Location	55 Corporate Drive, Brigewater, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1720525827
Provider Enumeration Date: 01/26/2017
Last Update Date: 01/26/2017

Medical Identifiers

Medical identifiers for Dr Lu Amy Sun such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720525827	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	432905 (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Lu Amy Sun is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Lu Amy Sun, MD 55 Corporate Drive, Brigewater, NJ 08807-2742 Ph: (215) 622-5386	Dr Lu Amy Sun, MD 55 Corporate Drive, Brigewater, NJ 08807-2742 Ph: (215) 622-5386

News Archive

Study reveals prevalence of multimorbidity among people using methamphetamine

People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health.

Genzyme signs repurchase agreement with Goldman, Sachs

Genzyme Corporation announced today that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $1 billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme's overall $2 billion share repurchase plan announced in May.

Hypoxic exosomes promote stemness in EWS sarcoma, indicates study

The cover for issue 40 of Oncotarget features Figure 5, "miR-210 silences the proapoptosis member CASP8AP2," by Kling, et al. which reported that hypoxic Ewing's sarcoma cells release exosomes that promote sphere formation, a stem-like phenotype, in EWS cells by enhancing survival.

Penn Medicine researchers show predictive power of overlooked lymph nodes

For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes-known as the posterior intercostal lymph nodes-that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.

Dr Lu Amy Sun, MD - Internal Medicine in Brigewater, NJ